In this episode of the Inflection Point I have an insightful conversation with Kyle Jackson. Kyle is a CHIR Vanier Scholar and senior PhD Candidate at McMaster University studying Bioengineering. His research explores the use of genetically modified bacterial viruses and engineered proteins as therapeutic strategies for Inflammatory Bowel Disease and other gut-based diseases. He has published 14 peer-reviewed publications and conference presentations, and raised over $1.5 million CAD in non-dilutive research funding. Kyle has a keen interest in synthetic biology and its applications in modern medicine. Prior to starting his PhD, Kyle did an undergraduate degree at McMaster University in the Biomedical Discovery & Commercialization Program. Outside of academia, Kyle is the Ontario Director of Investments at Front Row Ventures, Canada’s leading student-focused VC firm, and is also a Senior Fellow at HaloHealth, Canada’s largest MD-Angel Investor syndicate. When not working, you can often find Kyle at the golf range, listening to podcasts, or reading a good book. Hit that play button and dive right into the world of student VC in Canada.